The rising costs of healthcare and disease prevalence pose a major challenge to the availability, affordability and accessibility of high-quality care. Unserved disease markers, misdiagnosis and delayed detection remain a major challenge for health on both the individual and population level, as current lab-based diagnostics are still too slow, expensive and unfit for decentralised care.
BioChips
- Robyn Laskey Categorieën: